Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q88875044 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000052.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q88875044 | ||
024 | ‡a 0000-0002-8437-7539 ‡2 orcid | ||
035 | ‡a (OCoLC)Q88875044 | ||
100 | 0 | ‡a Allison Winter ‡c researcher ‡9 en | |
400 | 0 | ‡a Allison Winter ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study | ||
670 | ‡a Author's Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis | ||
670 | ‡a Author's Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. | ||
909 | ‡a (orcid) 0000000284377539 ‡9 1 | ||
919 | ‡a efficacyofbendamustineandrituximabinunfitpatientswithpreviouslyuntreatedchroniclymphocyticleukemiaindirectcomparisonwithibrutinibinarealworldsettingagimemaericandusstudy ‡A Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study ‡9 1 | ||
919 | ‡a outcomesandfactorsimpactinguseofaxicabtageneciloleucelinpatientswithrelapsedorrefractorylargebcelllymphomaresultsfromanintentiontotreatanalysis ‡A Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis ‡9 1 | ||
919 | ‡a prognosticvalueofpretransplantpetctinpatientswithdiffuselargebcelllymphomaundergoingautologousstemcelltransplantation ‡A Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. ‡9 1 | ||
996 | ‡2 NTA|411957503 | ||
996 | ‡2 DBC|87097969094961 | ||
996 | ‡2 ISNI|0000000080343310 | ||
996 | ‡2 ISNI|0000000391589617 | ||
996 | ‡2 SUDOC|059409282 | ||
996 | ‡2 RERO|A003161434 | ||
996 | ‡2 BNF|16198617 | ||
996 | ‡2 NTA|069308845 | ||
996 | ‡2 LC|n 98047820 | ||
996 | ‡2 NTA|072754311 | ||
996 | ‡2 PTBNP|1492470 | ||
996 | ‡2 NTA|433960957 | ||
996 | ‡2 RERO|A006003527 | ||
996 | ‡2 ISNI|0000000083781850 | ||
996 | ‡2 LC|n 90641611 | ||
996 | ‡2 ISNI|0000000079068104 | ||
996 | ‡2 SUDOC|145536998 | ||
996 | ‡2 DNB|1050533941 | ||
996 | ‡2 ISNI|0000000073938658 | ||
996 | ‡2 RERO|A003980191 | ||
996 | ‡2 NUKAT|n 2013185138 | ||
996 | ‡2 LC|no2021121913 | ||
996 | ‡2 JPG|500054065 | ||
996 | ‡2 PLWABN|9812443679805606 | ||
996 | ‡2 DNB|100703879 | ||
996 | ‡2 J9U|987007270031105171 | ||
996 | ‡2 DNB|120468026 | ||
996 | ‡2 CAOONL|ncf11011746 | ||
996 | ‡2 NUKAT|n 2012218022 | ||
996 | ‡2 DNB|173380514 | ||
996 | ‡2 ISNI|0000000394090563 | ||
996 | ‡2 NTA|180796267 | ||
996 | ‡2 CAOONL|ncf10196704 | ||
996 | ‡2 NTA|07167716X | ||
996 | ‡2 CAOONL|ncf10003768 | ||
996 | ‡2 BNE|XX6273155 | ||
996 | ‡2 PLWABN|9810705801905606 | ||
996 | ‡2 PLWABN|9810562893105606 | ||
996 | ‡2 NTA|072843020 | ||
996 | ‡2 DNB|127852360 | ||
996 | ‡2 NII|DA1741631X | ||
996 | ‡2 RERO|A017737372 | ||
996 | ‡2 LC|no2018055346 | ||
996 | ‡2 LC|n 86008859 | ||
996 | ‡2 BIBSYS|1542227320328 | ||
996 | ‡2 BIBSYS|99016326 | ||
996 | ‡2 ISNI|0000000486635583 | ||
996 | ‡2 ISNI|000000006146706X | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |